Evaluating supervised exercise for cancer patients
Study of the Effectiveness and Safety of Supervised Therapeutic Exercise in Cancer Patients With and Without Simultaneous Chemotherapy, Radiotherapy or Hormonal Treatment.
This study is testing if supervised exercise can help improve the quality of life for people with breast and colon cancer, whether they are receiving other treatments or not.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 78 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Universidad Complutense de Madrid Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Madrid and 1 other locations) |
| Trial ID | NCT05816187 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to assess the effectiveness of supervised therapeutic exercise in improving the quality of life for patients with breast and colon cancer, both with and without concurrent treatments such as chemotherapy or radiotherapy. The study involves 78 participants who will be randomly assigned to different groups: those receiving supervised exercise, those exercising independently, and a control group. The intervention lasts for six weeks, with follow-up assessments at multiple intervals to evaluate changes in quality of life using standardized questionnaires. The trial is designed to provide insights into the role of supervised exercise in cancer care.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-70 with stages I to III breast or colon cancer who have completed adjuvant treatment within the last 3 months to 2 years.
Not a fit: Patients with significant musculoskeletal or neurological disorders, or those unable to engage in physical activity, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of life for cancer patients undergoing treatment.
How similar studies have performed: Other studies have shown positive outcomes with supervised exercise in cancer care, suggesting this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18-70 years. * Oncological stage I, II or III. * Completed adjuvant treatment between 3 months to 2 years. ECOG 1-2. * Sign informed consent Exclusion Criteria: * Inability to read, understand and complete questionnaires, read and understand a brochure explanatory, understand and follow verbal orders (example; illiteracy, dementia or blindness). * Musculoskeletal disorders that prevent the exercise of the exercise bike, elliptical, march tape. * Important neurological disorders that involve impaired balance, coordination, ataxia. * Sporting activity at moderate intensity exceeding 150mnts / week. * Symptomatic anemia. * Fecal incontinence * Patient with a digestive ostomy. * Decompensated heart disease, * Uncontrolled hypertension * Heart failure. * Musculoskeletal pathology (except for upper limb pathology in cancer patients of mom) * Cardio-respiratory pathology that limits physical activity
Where this trial is running
Madrid and 1 other locations
- Hospital Universitario Infanta Leonor — Madrid, Spain (Recruiting)
- Hospital Universitario Infanta Leonor — Madrid, Spain (Active_not_recruiting)
Study contacts
- Study coordinator: Arturo Cano
- Email: arcano01@ucm.es
- Phone: 34611165586
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.